|19.30|| +0.10 / +0.52%|
Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
|Arthur P. Bedrosian||Chief Executive Officer & Director|
|Martin P. Galvan||CFO, Treasurer & Vice President-Finance|
|Robert Ehlinger||Chief Information Officer & VP-logistics|
|Kristie Stephens||Chief Compliance Officer & VP-Regulatory Affairs|
|John Abt||Vice President-Quality|